- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- January 2026
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- January 2026
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- December 2025
- 434 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- November 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2026
- 371 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 491 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 486 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 288 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 373 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 277 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 565 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 284 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 553 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 220 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- November 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP

Downstream Processing (DSP) is a biotechnology process used to purify and concentrate biopharmaceuticals, such as proteins, antibodies, and enzymes. It is a critical step in the production of biopharmaceuticals, as it ensures the quality and safety of the final product. DSP involves a series of steps, such as filtration, chromatography, and ultrafiltration, to separate and purify the desired product from the rest of the components. The process is highly complex and requires specialized equipment and expertise.
The DSP market is growing rapidly, driven by the increasing demand for biopharmaceuticals and the need for efficient and cost-effective production processes. The market is expected to continue to grow in the coming years, driven by technological advancements and the increasing demand for biopharmaceuticals.
Some of the major companies in the DSP market include Merck KGaA, GE Healthcare, Thermo Fisher Scientific, Sartorius AG, and Pall Corporation. Show Less Read more